Vancouver Declaration II on Global Headache Patient Advocacy 2019

• DOI: 10.1177/0333102420921162
• Publication Date: 2020-04-29T01:28:43Z
• Authors: David W Dodick; Messoud Ashina; Fumihiko Sakai; Wolfgang Grisold; Hitoshi Miyake; Deborah Henscheid...; Audrey Craven; Elena Ruiz de la ...; Rachel Koh; Nikita Reznik; Lisa Bance; Elizabeth Leroux; Lars Edvinsson
• Keywords: Summit; Declaration; Mandate; Global Health

In 2017, the International Headache Society convened a Global Patient Advocacy Summit (GPAS-1) to begin collaborative effort involving patients, patient advocates, advocacy organizations, healthcare professionals, scientists, professional pain, neurology, and headache societies, pharmaceutical manufacturers, regulatory agencies advance issues of importance patients affected by worldwide. September 2019, second (GPAS-2) was revisit from inaugural meeting, assess progress Coalition (IHS-GPAC) in meeting goals set forth therein, discuss strategies for achieving established supporting future development. Short- long-term mandates first were realized, including publishing Vancouver Declaration on 2018, determining governing operational structures IHS-GPAC, helping facilitate World Federation Neurology Brain Day dedicated migraine. Another short-term mandate, creating unified strategy, fulfilled Coalition's decision focus encouraging support employers implementing employee programs people with To help execute is developing an employer engagement toolkit that will educate employees about impact migraine workplace, reduce stigma directed toward migraine, care burden illness improve workplace productivity. members disseminate encourage adoption The has alliance two global, multinational expand awareness among policy makers other stakeholders around world. IHS-GPAC met many at GPAS-1, it initiated global strategy focused psychosocial economic toll disorders, especially workplace. Ongoing activities explore range opportunities across full spectrum goals.